The U.S. Food and Drug Administration (FDA) is reorganizing its leadership in drug and biologics regulation following the resignation of former commissioner Marty Makary. Acting directors Tracy Beth Høeg and Katherine Szarama are leaving their roles, with Karim Mikhail and Michael Davis stepping in as replacements. This leadership change comes amid ongoing turnover challenges at the agency under the Trump administration, which is also working to fill other key health positions like CDC director and surgeon general. A permanent commissioner nominee is expected soon, pending Senate confirmation.
Constellation Software Inc. held its annual general meeting on May 15, 2026, where all nine director nominees were successfully elected by shareholders. Mark Leonard, the company's founder and former president, did not seek re-election but will remai...
First Trust Portfolios Canada announced the cap at 17.23% and a 10% buffer for the First Trust Vest U.S. Equity Buffer ETF (MAYB.F) for its new Target Outcome Period from May 19, 2026, to May 21, 2027. The fund aims to match returns of the SPDR S&P 5...
Roger Williams University celebrated its Class of 2026 with a Commencement ceremony emphasizing mentorship, trust, and lifelong learning. Keynote speaker Dick Sullivan ’79, former CEO of PGA TOUR Superstore, highlighted mentorship as crucial for care...
Conrad Industries announced its financial results for Q1 2026, reporting a net income of $3.2 million and earnings per diluted share of $0.64, down from $3.9 million and $0.77 respectively in Q1 2025. The company signed $46.8 million in new construct...
ImagineAR Inc. announced a non-brokered private placement to raise up to $500,000 by selling 100 million share units at $0.005 each, including warrants exercisable at $0.05 for 36 months. The funds will support ongoing litigation against Niantic, dev...
